Source link : https://www.newshealth.biz/health-news/fostamatinib-fails-to-improve-outcomes-in-hypoxemic-covid-patients/
The spleen tyrosine kinase inhibitor fostamatinib (Tavalisse) did not improve outcomes in adults hospitalized with COVID-19 and hypoxemia, according to a phase III trial published in JAMA Network Open. In this exclusive MedPage Today video, Sean P. Collins, MD, MSc, of Vanderbilt University Medical Center in Nashville, Tennessee, discusses the implications of the trial findings, […]
Author : News Health
Publish date : 2024-12-06 15:06:35
Copyright for syndicated content belongs to the linked Source.
Categories